Welcome to LookChem.com Sign In|Join Free

Xi`an Eastling Biotech Co., Ltd.

Diamond Supplier

Diamond
Supplier
1st
years
Home>>Products>>High Purity 99% Compound 7P CAS 1890208-58-8

Product Certification&
Enterprise Certification

More Detail

Xi`an Eastling Biotech Co., Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.Spike

Tel: +86-156-91766041

Mobile:

Tel: +86-156-91766041

Fax:

URL: http://www.eastlingbiotech.com/

Province/state: Shaanxi

City: Xi'an city

Street: No. 201, Unit 4, Building 9, Hongqi Community, Tanjia Street, Weiyang District, Xi 'an, Shaanxi

MaxCard:


Contact Suppliers

High Purity 99% Compound 7P CAS 1890208-58-8

CAS NO.1890208-58-8

  • FOB Price: USD: 3,300.00-3,300.00 /Kilogram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: L/C,D/A,D/P,T/T,Other
  • Available Specifications:

    99%(1-10)Kilogram

Contact Supplier

Product Details

Keywords

  • Compound 7P
  • 1890208-58-8
  • 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide

Quick Details

  • ProName: High Purity 99% Compound 7P CAS 189020...
  • CasNo: 1890208-58-8
  • Molecular Formula: C22H23N3O5S
  • Appearance: White powder
  • Application: Dietary supplements, supplements,
  • DeliveryTime: 1-3days
  • PackAge: 100 gram/ bag, 1kg/ bag, 25kgs/ drum?
  • Port: China main port
  • ProductionCapacity: 100 Kilogram/Month
  • Purity: 99.9%
  • Storage: Store in tight, light-resistant contai...
  • Transportation: by air
  • LimitNum: 1 Gram
  • Heavy Metal: ≤10PPM
  • Valid Period: 2 years

Superiority

We have strong ability to finish your private labels. Most retailers have their own brand, they need customized supplements and packaging services. If you are seeking to a trusted manufacturer, we can promise you that adding your company name, creating your design or customized packaging services. Private label products are one of the most best selling customized orders.

 

Details

Compound 7p was shown to induce the growth of GAP-43-positive axons in an animal model of optic nerve injury, suggesting that the neurite outgrowth activity of compound 7p in vitro translates into stimulation of axon regeneration in vivo. Compound 7P powder is a white to off-white powder produced as a tandem compound for the identification of dual-acting thromboxane receptor antagonist inhibitors. Indeed, compound 7p exhibits selectivity for prostaglandin I2 synthase (PTGIS, CYP8A1) over thromboxane synthase (CYP5A1). A nootropic is any substance that helps improve brain function, including memory, concentration, mood, and even intelligence. They can range from certain food groups or items to man-made compounds specifically designed to aid brain function and other benefits. Nootropic compound 7P powder promotes outgrowth of Gap-43 positive axons, thereby stimulating axonal regeneration in vivo. High-quality compound 7p is designed to improve coordination, improve mood and help fight fatigue. It also prevents oxidation of the brain and helps fight brain damage caused by alcohol consumption.

Product name

Compound 7P

Other names

Compound7P;

2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;

2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide

CAS No.

1890208-58-8

Molecular formula

C22H23N3O5S

Molecular weight

441.51

Purity

99.0%

Appearance

White powder

Application

Nootropic

 Neurons in the adult central nervous system (CNS) fail to regenerate axons after injury, which in part explains poor functional recovery in patients with trauma and neurodegenerative diseases. Compound 7p, which enhances neurite outgrowth in cultured primary neurons derived from the hippocampus, cerebral cortex, and retina, and induces optic nerve regeneration in an animal model of optic nerve injury. It also increases coordination, treats alcohol-related brain damage, and prevents oxidation around the brain. Also helps to improve one's mood and fight fatigue. Additionally compound 7P showed the highest activity against cervical tumors by improving the microstructure in a dose-dependent manner. Further optimization of compound 7p and elucidation of the mechanism by which it triggers axon regeneration in vivo will provide a rationale for future efforts to strengthen therapeutic strategies.